How snake venom disintegrins affect platelet aggregation and cancer proliferation

Toxicon. 2023 Jan 1:221:106982. doi: 10.1016/j.toxicon.2022.106982. Epub 2022 Nov 23.

Abstract

Disintegrins are small peptides possessing a tripeptide motif capable of binding to integrins. These were first isolated from viper venoms and are now also found in many other hematophagous organisms. Many integrins have been studied for their role in the onset of disease and the interaction of disintegrins with these receptors makes them potential therapeutic molecules. Disintegrins are also used as molecular scaffolds to design effective drugs for cardiovascular diseases and cancer. Even the gene and protein sequencing data of disintegrins have provided insights into understanding the molecular complexity of disintegrins. In this review, we try to summarize the structural and functional importance of disintegrins in identifying the biological targets and triggering various signaling pathways involved in platelet aggregation and cancer. Also, we have tried to elucidate a possible molecular mechanism behind the action of disintegrins on platelet aggregation and cancer. This understanding will help us to design and to explore more of these integrin-binding molecules.

Keywords: Anti-oncogenic; Evolution; Integrins; Platelet aggregation; RGD motif; Viper venom disintegrins.

Publication types

  • Review

MeSH terms

  • Cell Proliferation
  • Disintegrins* / chemistry
  • Humans
  • Integrins / metabolism
  • Neoplasms* / drug therapy
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors / chemistry
  • Snake Venoms / chemistry
  • Viper Venoms / chemistry

Substances

  • Disintegrins
  • Platelet Aggregation Inhibitors
  • Snake Venoms
  • Integrins
  • Viper Venoms